Neurophyxia

1 known investors

Neurophyxia is a clinical-stage drug development company developing therapies to reduce brain damage caused by oxygen shortage. Its lead product, 2-IB, is in Phase IIb/III clinical development, focused primarily on stroke, with additional indications including birth asphyxia and cardiac arrest.

BiotechMedical Devices